Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution

Clinical Infectious Diseases

Volumn 36, Issue 12, 2003, Pages 1539-1544

  Allon, Michael ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Cardio Renal Physiology and Medicine Division of Nephrology Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; HEPARIN DERIVATIVE; TAUROLIDINE; TISSUE PLASMINOGEN ACTIVATOR; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; TAURINE; THIADIAZINE DERIVATIVE;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BIOFILM; CATHETER INFECTION; CATHETER LOCK SOLUTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INSTILLATION; DRUG SOLUTION; FEMALE; FIBRINOLYTIC THERAPY; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL; ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; INDWELLING CATHETER; MICROBIOLOGY; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETERIZATION; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TAURINE; THIADIAZINES;

EID: 0038548201     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375234     Document Type: Article

References (30)

1. Schwab SJ, Beathard GA. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999; 56:1-17.
2. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002; 15:162-71.
3. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med 1992; 20:665-73.
4. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
5. Donlan RM. Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 2001; 33:1387-92.
6. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881-90.
7. Marr KA, Sexton DJ, Conlon PJ, et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127:275-80.
8. Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis 1995; 25:593-6.
9. Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 1998; 53:1792-4.
10. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10:1045-9.
11. Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000; 57:2151-5.
12. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-72.
13. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61:1136-42.
14. Daeihagh P, Jordan J, Chen GJ, Rocco M. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 2000; 36:75-9.
15. Mokrzycki MH, Jean-Jerome K, Rush H, et al. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001; 59:1935-42.
16. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13:2133-9.
17. Traub WH, Leonhard B, Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993; 39:322-30.
18. Torres-Viera C, Thauvin-Eliopoulos C, Souli M, et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother 2000; 44:1720-4.
19. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46:1674-9.
20. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998; 22:242-4.
21. Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif 2001; 19:251-4.
22. Allon M, Bailey R, Ballard R, et al. A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int 1998; 53:473-9.
23. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34:1114-24.
24. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35:1281-307.
25. Blenkharn JI. Antibacterial and related properties of taurolin - a survey. In: Reding R, Verlag TM, eds. Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen, Neptun-Symposium Rostock. International Communications and Translations (ICA) no. 30871. Philadelphia: ICA, 1991:143-51.
26. Buturovic J, Ponikvar R, Kandus A, et al. Filling hemodialysis catheters in the interdialytic period. Heparin versus citrate versus polygeline: a prospective, randomized study. Artif Organs 1998; 22:945-7.
27. Swartz RD, Messana JM, Boyer CJ, et al. Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol 1994; 4:1719-25.
28. Lund GB, Trerotola SO, Scheel PF, et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996; 198:467-72.
29. D'Agata EMC. Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 2002; 35:1212-8.
30. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.